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This work aims to validate the clinical significance of coronary artery calcium score (CACS) in predicting coronary artery disease
(CAD) and cardiac events in 100 symptomatic patients (aged 37–87 years, mean 62.5, 81 males) that were followed up for a mean
of 5 years. Our results showed that patients with CAD and cardiac events had significantly higher CACS than those without CAD
and cardiac events, respectively. The corresponding data were 1450.42 ± 3471.24 versus 130 ± 188.29 (𝑃 < 0.001) for CAD, and
1558.67 ± 513.29 versus 400.46 ± 104.47 (𝑃 = 0.031) for cardiac events. Of 72 patients with CAD, cardiac events were found in
56 (77.7%) patients. The prevalence of cardiac events in our cohort was 13.3% for calcium score 0, 50% for score 11–100, 56% for
score 101–400, 68.7% for score 401–1,000, and 75.0% for score >1000. Increased CACS (>100) was also associated with an increased
frequency of multi-vessel disease. Nonetheless, 3 (20%) out of 15 patients with zero CACS had single-vessel disease. Significant
correlation (𝑃 < 0.001) was observed between CACS and CAD on a vessel-based analysis for coronary arteries. It is concluded that
CACS is significantly correlated with CAD and cardiac events.
1. Introduction
The pathogenesis of coronary artery disease (CAD) is a
long-term atherosclerotic process that eventually leads to
significant stenosis (decrease of lumen diameter by >50%) of
the coronary arteries. With reports demonstrating the initial
presentation of CAD being acute myocardial infarction or
sudden cardiac death in 50% of patients [1], increasing efforts
have beenmade to establish risk factors that can assess patient
risk for future coronary events. Unfortunately, the success of
conventional risk factors, such as the FraminghamRisk Score,
clinical examination, and stress testing, have been limited
in their ability to predict the occurrence of CAD, especially
among patients within the intermediate risk group [2].
Coronary artery calcium score (CACS) has been regarded
as a potential tool to improve risk stratification and predict
cardiac events. It has been recognized as a surrogate marker
for atherosclerotic plaque burden and holds the advantages of
directly visualizing and precisely locating the plaques using
computed tomography (CT) [3, 4]. Using Agatston calcium
scoring [5], CACS can also be quantified, allowing for a direct
individual assessment of each patient, unlike conventional
risk factors that only provide a statistical probability for
patients developing CAD. A growing number of reports
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have emerged supporting the vital use of CACS in the
assessment of cardiac event risk stratification [3, 6]. Con-
ventional coronary angiography (CCA) is the gold standard
in diagnosing CAD due to its superior spatial and temporal
resolution, thus enabling accurate assessment of the degree of
coronary stenosis. However, this procedure remains invasive,
expensive, and inconvenient for patients. CACS, on the other
hand, ismost commonly quantified using CT, which is widely
used in routine clinical practice as a noninvasive technique.
The vast majority of studies describing the prognostic
value of coronary calcification were mainly done in the
Western countries [7–10]. Related studies reported from
Asian country are relatively scarce [11, 12]. The healthcare
system, populations, and disease patterns in Asia differ from
Western countries [13]. Prevalence of coronary calcification
is different in Caucasian, Chinese, Hispanic, and African
populations by figures of 70.4%, 59.6%, 56.5%, and 52.1%,
respectively. Compared with Caucasians, the relative risk of
death was 2.97 in Africans, 1.58 in Hispanics, and 0.85 in
Chinese [2]. In this report from an Asian country, we aim to
validate the relationship between CACS, CAD, and cardiac
events by using 64-multislice computed tomography (64-
MSCT) with CCA as the gold standard.
2. Materials and Methods
2.1. Patients. Medical records of CCA and CACS over 2 years
(2006–2008) fromChangGungMemorialHospital in Taiwan
were retrospectively reviewed of 100 symptomatic patients
suggestive of CAD. These symptomatic patients included 81
men, with ages ranging from 37 to 87 (mean 62.5) years.
The main symptoms prior to CCA and 64-MSCT testing
included chest tightness (𝑛 = 57), chest pain (𝑛 = 44),
radiating pain (𝑛 = 26), dyspnea (𝑛 = 38), and cold sweats
(𝑛 = 25). Risk factors for CAD that were apparent among
the patient population included hypertension (𝑛 = 61),
hypercholesterolemia (𝑛 = 27), hypertriglyceridemia (𝑛 =
36), smoking history (𝑛 = 14), diabetes mellitus (𝑛 = 22),
and obesity or overweight (𝑛 = 33). All patients underwent
CCA and MSCT for CACS. The interval between the testing
of CCA and 64-MSCT ranged from 0 to 89 (mean 9.16 ±
16.82) days, where the interval was less than two weeks in
79% of all cases. For assessing cardiac events after cardiac
CT, 98 patients could be followed up for a mean of 5 years
(range 46.7–72.9 months). Each subject was recorded to have
at least one cardiac event, by definition as occurrence of
either unstable angina requiring revascularization or cardiac
death (caused by acute myocardial infarction, ventricular
arrhythmias, or refractory heart failure). The institute review
board approved the study, and written informed consent
was obtained from all patients undergoing CCA and CT.
Patients were excluded if they had contrast medium allergy,
impaired renal function, history of coronary bypass surgery,
and arrhythmia.
2.2. Conventional Coronary Angiography (CCA). CCA was
referred to all patients with suspected CAD, as described by
their symptoms, risk factors, and experiencing at least one
cardiac event. CCA was done accordingly to the standard
Seldinger’s technique on an angiographic machine (Integris
BH3000, Philips, Eindhoven, The Netherlands) by femoral
approach. Cardiologists who had no prior knowledge of
MSCT findings quantitatively analyzed the severity of coro-
nary stenosis. The minimal lumen diameter was measured
in projections showing the most severe narrowing. The
degree of stenosis was classified into four categories: (1) no
stenosis, (2) minimal or mild stenosis (≤50%), (3) moderate
stenosis (50%–70%), and (4) severe stenosis (>70%). CAD
was definedwhen lumen diameter reductionwas greater than
50% (moderate or severe stenosis).
2.3. Cardiac CT Imaging Protocol. All CT scans were per-
formed on a 64-slice scanner with a 0.4 s rotation time
(Aquilion Multi-64-slice system, Toshiba Medical Systems).
Nonenhanced CT scan for calcium scoring was performed
from the level of tracheal bifurcation to the diaphragm
using the following parameters: 120KVp, 300mA, 0.25 s,
slice thickness of 3mm, and intervals of 3mm. The calcium
scores of each area at each vessel were calculated at an
offline commercially available workstation with dedicated
software (Software Vitrea 2 V3.9.0.1, MN, USA) and the
scores were quantified by the scoring algorithm proposed by
Agatston et al. [5], and calcium scores were divided into the
following categories: 0, 1–10, 11–100, 101–400, 401–1000, and
≥1000.
2.4. Statistical Analysis. Continuous variables were expressed
as mean and standard deviations. For both patient-based
and vessel-based analyses, Kruskal-Wallis test was used to
analyze whether the CACS were related to the degree of
coronary artery stenosis. Mann-Whitney U test was used
to investigate the correlation between the CACS and the
presence of CAD. Two-sample independent t-test was used
to analyze the correlation between CACS and cardiac events.
Chi-square test was used to assess the correlation between
the cardiac events and categorical variables (age, gender, risk
factors including hypertension which was defined as blood
pressure> 130/90mm Hg, diabetes mellitus, smoking, body
mass index, and hypercholesterolemia). Event-free survival
curves were constructed using the Kaplan-Meier method to
account for censored survival times and compared with the
log-rank test. A 𝑃 value of less than 0.05 was considered
statistically significant.
3. Results
3.1. Significant Correlation between CACS and CAD on a
Patient Basis. Of 100 symptomatic patients, CCA revealed
CAD (stenosis >50% in diameter) in 72 patients, while the
remaining 28 patients had noCAD (stenosis≦ 50%) (Table 1).
Among the patients diagnosed with CAD, 57 had severe
stenosis and 15 had moderate stenosis. On the other hand,
9 patients had minimal or mild stenosis and 19 patients
had no stenosis. Our findings indicated that: (1) there was
a significant increase in mean calcification with increasing
severity in stenosis, (2) the variability of calcium scoring was
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Table 1: The correlation between calcium scoring and degree of stenosis, coronary artery disease (CAD) and cardiac events.
Calcium scoring 0 1–10 11–100 101–400 401–1000 ≧1001
Number of cases 15 0 16 25 16 28
Cardiac events+ (n = 56) 2 (13.3%) 0 8 (50%) 14 (56%) 11 (68.7%) 21 (75%)
Degree of stenosis (𝑛 = 100) Mean ± SD
0 = no (n = 19) 10 (66.7%) 0 4 (25%) 3 (16%) 2 (12.5%) 0 87.32 ± 156.52∗
1 = minimal or mild (n = 9) 2 (13.3%) 0 2 (12.5%) 3 (12%) 2 (12.5%) 0 220.11 ± 225.99∗
2 = moderate (n = 15) 1 (6.7%) 0 1 (6.3%) 4 (12%) 3 (18.8%) 6 (21.4%) 1143.87 ± 1284.63∗
3 = severe (n = 57) 2 (13.3%) 0 9 (56.2%) 15 (60%) 9 (56.2%) 22 (78.6%) 1531.09 ± 3851.32∗
No CAD = 0 + 1 (n = 28) 12 0 6 6 4 0 130 ± 188.29∗
CAD = 2 + 3 (n = 72) 3 0 10 19 12 28 1450.417 ± 3471.24∗
Coronary artery disease (𝑛 = 72)
One vessel (n = 33) 3 (100%) 0 10 (100%) 8 (42.1%) 6 (50%) 6 (21.4%)
Two vessels (n = 26) 0 0 0 8 (42.1%) 3 (25%) 15 (53.6%)
Three vessels (n = 13) 0 0 0 3 (15.8%) 3 (25%) 7 (25%)
∗Statistically significant (𝑃 < 0.001).
+Followup for cardiac events was successful in 98 of 100 patients.
Table 2: Calcium score in vessel-based distribution of coronary artery stenosis or coronary artery disease (CAD).
Degree of stenosis RCA (𝑛 = 100) LM (𝑛 = 100) LAD (𝑛 = 100) LCX (𝑛 = 100)
𝑛 Mean ± SD 𝑛 Mean ± SD 𝑛 Mean ± SD 𝑛 Mean ± SD
0 = no 51 116.53 ± 303.26∗ 81 52.38 ± 121.98 37 162.57 ± 394.78∗ 59 78.47 ± 196.89∗
1 = minimal or mild 11 216 ± 242.06∗ 6 137.50 ± 135.44 14 214.07 ± 270.84∗ 10 133.20 ± 246.96∗
2 = moderate 13 289 ± 405.06∗ 6 135.71 ± 217.82 15 673.67 ± 270.84∗ 8 113.38 ± 104.17∗
3 = severe 25 1344.52 ± 3637.06∗ 7 186.83 ± 188.72 34 361.06 ± 415.86∗ 23 475.09 ± 1011.95∗
No CAD = 269 62 134.18 ± 297.28∗ 87 58.25 ± 124.86 51 176.71 ± 365.0∗ 69 86.41 ± 205.9∗
CAD = 131 38 1017.63 ± 3039.3∗ 13 159.31 ± 206.48 49 456.76 ± 515.4∗ 31 381.74 ± 887.4∗
RCA: right coronary artery, LM: left main coronary artery, LAD: left anterior descending artery, and LCX: left circumflex artery.
∗Statistically significant (𝑃 < 0.001).
high within each group, and (3) the overall calcium score
in patients with CAD was significantly higher than those
without CAD (1450.42 ± 3471.24 and 130 ± 188.29, resp.;
𝑃 < 0.001) (Table 1).This suggests that patientswith extensive
coronary calcification have a higher probability of moderate
stenosis and, thus, are more likely to have CAD. Patients with
a calcium score of 0, 11–100, 101–400, 401–1000, and >1000
had a 20%, 62.5%, 76%, 75%, and 100% prevalence of CAD,
respectively (Table 1). A significant correlationwas confirmed
between the degree of stenosis and calcium score (𝑃 < 0.001)
(Table 1).
3.2. Significant Correlation between CACS and CAD on a
Vessel Basis. Among the 100 patients, a total of 400 vessels
were analyzed in which CAD (severe or moderate stenosis)
was found in 131 vessels, and no CAD was found in the
remaining 269 vessels (Table 2). Of the 131 vessels with
significant stenosis, 38 were in the right coronary artery
(RCA) (29%), 13 were in the left main artery (LM) (9.9%),
49 were in the left anterior descending (LAD) (37.4%), and 31
were in the left circumflex artery (LCX) (23.7%). As expected,
CACS was significantly greater in patients with CAD than
those without CAD, with the corresponding CACS being
1017.63 ± 3039.32 and 134.18 ± 297.28, respectively, in the
RCA (𝑃 < 0.001), 456.76 ± 515.48 and 176.71 ± 365.09,
respectively in the LAD (𝑃 < 0.001), and 381.74 ± 887.48
and 86.41 ± 205.94, respectively, in the LCX (𝑃 < 0.001).
CACSwas lower in the LM compared to all other blood vessel
in both CAD and non-CAD patient groups. Also, marginal
significant findings between the CACS and patients with
and without CAD were noticed in the LM (159.31 ± 206.48
and 58.25 ± 124.86, resp.; 𝑃 = 0.055). Our results revealed
a positive correlation between greater calcium score and
the frequency of multivessel disease (Table 1). Specifically,
all patients with multivessel disease (CAD in two or three
arteries) had a calcium score that was at least greater than 100
and patients with CACS > 1000 had a 100% incidence of CAD
(𝑃 < 0.001) (Figure 1).
The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV), and accuracy of
CACS at different score levels are analyzed in Table 3. Using
CCA as the gold standard, in patient-based analysis, CACS
of 11–100 yielded the highest sensitivity (95.8%), NPV (80%),
and accuracy (80%). CACS of over 1000 revealed the greatest
specificity (100%) and PPV (100%). For each coronary artery,
CACS of 1–10 yielded the highest sensitivity (91.6%) andNPV
4 BioMed Research International
Table 3: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of calcium scoring in assessing
coronary artery disease under patient-based (PB) and vessel-based (VB) analyses.
Calcium scoring 0 1–10 11–100 101–400 401–1000 ≧1001
PB VB PB VB PB VB PB VB PB VB PB VB
Sensitivity 100% 100% Nil 91.6% 95.8% 86.3% 81.7% 61.1% 56.3% 33.6% 39.4% 11.5%
Specificity 0% 0% Nil 46.1% 41.4% 53.2% 62.1% 77.3% 86.2% 91.8% 100% 98.9%
PPV 32.8% 71% Nil 45.3% 80% 47.3% 84.1% 56.7% 90.9% 66.7% 100% 83.3%
NPV Nil Nil Nil 91.9% 80% 88.8% 58.1% 80.3% 44.6% 74% 40.3% 69.6%
Accuracy 32.8% 71% Nil 61% 80% 64% 76% 72% 65% 72.8% 57% 70.3%
Nil: no patients in respective group.
(a) (b)
Figure 1: A 86-year-old female with two-vessel coronary artery disease, total calcium score was 1278. The calcium score was 325 over the
right coronary artery (RCA). (a) A computed tomographic angiogram shows mixed plaques over the middle third of RCA with 54% stenosis
(white arrow). (b) Conventional coronary arteriogram confirms the moderate stenosis over the proximal as well as middle (arrow) third of
RCA.
(91.9%), and CACS of >1000 revealed the highest specificity
(98.9%) and PPV (83.3%). The greatest accuracy (72.8%) was
obtained with CACS of 401–1000.
3.3. Zero CACS Scoring Cannot Exclude the Presence of CAD.
A total of 15 patients did not have coronary calcification, with
3 (20%) of them having CAD (Table 1), indicating that the
complete absence of coronary calcium did not exclude the
presence of CAD. Following the analysis of the 3 patients
with zero CACS, all were found to have single-vessel CAD
primarily involving the LAD (Table 1). All three patients
were confirmed to have soft plaques on CT angiograms
(Figures 2(a) and 3(a)). One patient had moderate stenosis
and 2 had severe stenosis confirmed by CCA (Figures 2(b)
and 3(b)).
3.4. A Significant Correlation between CACS and Cardiac
Events. Of 98 patients with a mean followup of 5 years,
cardiac events occurred in 56 (57.1%) patients which were
all associated with CAD. These cardiac events included two
cardiac deaths (no revascularization) and 54 revasculariza-
tion (Table 1) including 3 subsequent cardiac deaths. Of 72
patients with CAD, cardiac events were encountered in 56
(77.7%) subjects. Patients with cardiac events had statistically
significant higher CACS than those without cardiac events:
1558.67 ± 513.29 versus 400.46 ± 104.47 (𝑃 = 0.031). Cardiac
events were not significantly related to patient age (𝑃 =
0.576), gender (𝑃 = 0.775), hypertension (𝑃 = 0.800),
body mass index (𝑃 = 0.815), smoking (𝑃 = 1.000), and
hypercholesterolemia (𝑃 = 0.410) but closely related to
diabetes mellitus (𝑃 = 0.021).
Figure 4 shows significant association of coronary
stenosis with major adverse cardiac events. The cumulative
event-free subjects curves according to calcium score
categories are reported in Figure 5. As shown in these two
figures, significant associations were found between the
degree of coronary stenosis and calcium scores and the
occurrence of cardiac events.
4. Discussion
The strength of our study is that it provides prognostic
information of CACS for cardiac events based on a mean
followup of 5 years. We also identify the clinical value of
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(a) (b)
Figure 2: A 53-year-old male with zero calcium score. (a) A computed tomographic angiogram shows a soft plaque at the left anterior
descending artery (LAD) (black arrow) with severe stenosis. (b) Conventional coronary arteriogram confirms the severe stenosis over the
proximal third of the LAD (white arrow).
(a) (b)
Figure 3: A 66-year-old male with zero calcium score. (a) A computed tomographic angiogram shows soft plaques (black arrows) at the
left anterior descending artery (LAD) with severe stenosis. (b) Conventional coronary arteriogram confirms the severe stenosis of the LAD
(white arrow).
using CACS for determining the presence and degree of
CAD, although a zero CACS cannot exclude the presence of
CAD.
Up to 50% of CAD patients initially suffer from acute
myocardial infarction (AMI) or sudden death [1], and the
severity of these hard cardiac events has prompted a greater
emphasis on preventative care. Thus, scoring tools that
consider demographic and clinical characteristics are used
to stratify patients into low-, intermediate-, and high-risk for
developing CAD. In addition to the Framingham Risk Score
(FRS) that uses a multivariable statistical model to predict a
patient’s 10-year risk for future cardiovascular events, other
tools include clinical examinations, stress testing, C-reactive
protein, and family history ofCAD.Nonetheless, such predic-
tion models for CAD have limitations [13]. Akosah et al. [14]
conducted a survey consisting of a groupof 222 asymptomatic
patients who suffered from their first AMI and found that
75% of them would not have been considered for therapy
according to conventional risk factors. Other studies have
shown that testing can only predict 60–65% of cardiovascular
events, leaving up to one-third of patients suffering from a
hard cardiac event in the absence of these risk factors [15].
Such shortcomings lie in that conventional risk factors only
provide a statistical probability of patients developing CAD,
rather than a direct individual assessment [16]. Patients in
the intermediate risk group are especially affected, as they are
left untreated due to cost inefficiency and their asymptomatic
condition results in poor compliance to lifestyle change [2].
The prognostic value of CACS over clinical and labora-
tory data has been previously studied in a large cohort of
patients [12, 16, 17]. These studies showed that an excellent
survival was achieved in patients with a zero CACS, but
increased cardiac events were closely associated with higher
CACS (<400).This is confirmed in our study as we found the
similar probability of 5-year cardiac events, which was 75%
for CACS> 1000 and 13.3% for CACS = 0. The occurrence
of cardiac events for the patients with a zero CACS is
significantly higher than that reported by Hou and others



















Figure 4: Cumulative event-free survival curves by Kaplan-Meier
analysis according to the degree of coronary stenosis.
[12, 16, 17]. This could be caused by the small sample size in
our study. We also found the correlation of severity of CAD
with adverse cardiac events, with severe coronary stenosis
leading to 86% cardiac events, and only 11.1% for patients with
mild degree of coronary stenosis. This indicates incremental
prognostic value of adding coronary stenosis to CACS over
clinical risk factors.
A growing number of reports have emerged supporting
the use of CACS as a diagnostic tool for asymptomatic
patients at intermediate risk for CAD and the diagnosis of
CAD in symptomatic patients [18, 19]. A study by Raggi et al.
[19] concluded that there was a greater incidence of hard
cardiac events (AMI and sudden death) in asymptomatic
patients who had calcium scores greater than the 75th
percentile when compared with their age- and sex-matched
controls. Another study reported the odds ratio of hard
cardiac events in asymptomatic patients with Agatston CACS
scores <100, 100–400, and >400 to be 2.1, 4.2, and 7.2, respec-
tively [20]. Among symptomatic patients, Georgiou et al. [7]
reported that calcium score values were significantly related
to occurrence of hard cardiac events (𝑃 < 0.001) and
all cardiovascular events (𝑃 < 0.001), whereby patients
with CACS in the upper third and fourth quartiles (greater
than the 75th percentile) were 13.2 times more likely to
suffer from an event than those with zero or low scores (0
to 25th percentile). Furthermore, Detrano et al. [9] have
reported that coronary calcium score is a strong predictor
of incident coronary heart disease events (MI, death due
to CAD) among four racial groups (Caucasian, African,





















Figure 5: Cumulative event-free survival curves by Kaplan-Meier
analysis according to the categories of coronary artery calcium score.
risk of coronary events associated with increasing CACS had
a hazard ratio (95%CI) of 1.00 for nondetectable calcium. For
CACS of 1–100, 101–300,>300, the hazard ratio was 3.89 (1.71–
8.79), 7.08 (3.05–16.47), and 6.84 (2.93–15.99), respectively.
Chinese people had a hazard ratio (95% CI) for the risk
of coronary heart disease with CACS of 1.25 (𝑃 = 0.11)
compared to the Caucasian people who had a hazard ratio
of 1.17 (𝑃 < 0.005). Our findings are in line with these
studies confirming the prognostic value of CACS in a group
of symptomatic patients.
According to a report by Budoff et al. [21], when com-
pared with individuals without calcium as a hazard ratio of
1, a calcium score between 1 and 100 was associated with
a “hazard ratio” for major coronary events of 3.9, a score
between 101 and 300 with a “hazard ratio” of 7.1, and a score of
more than 300 with a “hazard ratio” of 6.8. In this study, the
prevalence of cardiac events was 13.3% for calcium score 0,
50% for score 11–100, 56% for score 101–400, 68.7% for score
401–1,000, and 75% for score >1000. The mean of CACS in
our cohort with cardiac events (1559) was 3.9 times higher
than that of cohort without cardiac event (400). In addition to
higher CACS, the study also revealed significant correlation
(𝑃 = 0.021) between the diabetes mellitus and cardiac events.
It has been reported that type 2 diabetics with a CACS> 100
are expected to have an increased frequency of ischemia in
myocardial perfusion imaging; the risk of all-cause mortality
was higher in diabetics than in nondiabetics for any degree of
CS [22]. All our patients with a CACS above 1000 had CAD,
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calcium score higher than 1000 is associated with increased
specificity (100%) but decreased sensitivity (39.4%). Larger
angiographic studies using electron beam tomography and
electron beam computed tomography have reported similar
findings [22, 23].
A previous study by Budoff et al. [24] investigated
the distribution of calcification within the major coronary
arteries to determine the severity and extent of angiographic
disease. In another algorithmic model, Schmermund et al.
[25] utilized calcium scoring to distinguish patients with or
without 3-vessel and/or left main CAD. While recent studies
have found a moderate correlation between CACS and the
incidence of atherosclerotic disease on vessel-based analysis
(𝑟 = 0.521) [11], our study reveals more comprehensive
findings. We demonstrate (1) a statistically significant corre-
lation between the degree of stenosis and calcium score in
the RCA, LAD, and LCX (𝑃 < 0.001) and (2) a significantly
higher CACS in patients with CAD than those without
CAD in the three aforementioned coronary arteries (𝑃 <
0.001). Only the LM revealed nonsignificant correlation with
respect to CACS and the presence of CAD, although the
relationship between stenosis and calcium scoring was close
to significance (𝑃 = 0.055).This findingmay be a result of the
left main artery bifurcating into the LAD and LCX, and any
calcification near this junction could be assigned to varying
branches. Such difficulty in assigning calcifications to a single
artery could obscure the reported CACS in different blood
vessels.
Although the presence of coronary artery calcium is
associated with a greater risk of cardiovascular events, its
ability to predict future coronary events is not absolute. A
zero calcium score only reflects the absence of atherosclerotic
lesions with calcified plaques greater than 1mm in diameter,
leaving noncalcified and lipid-laden “vulnerable” plaques to
be present in the absence of CACS [26]. Furthermore, any
identified calcification only reflects approximately 20% of
the total atherosclerotic plaque burden, overlooking any soft
plaques that may cause CAD [27]. Nonetheless, the absence
of CAC is associated with a very low probability of significant
stenosis and future cardiovascular events.
A systematic review of 49 studies revealed that the
frequency of cardiovascular event among patients with zero
CACS was 0.56% in asymptomatic and 1.8% in symptomatic
patients [28].This review also found CACS to have a negative
predictive value as high as 99% for ruling out acute coro-
nary syndrome [29]. Similarly, another series reported that
obstructive CADwas found in 7% of patients with zero CACS
and in 17% of patients with low CACS (1–100) [30].
In our study, on a per-patient basis, 20% of patients (3
out of 15) with zero CACS had single-vessel CAD. Further
analysis revealed that these patients had soft plaques, which
was the cause of severe stenosis at the proximal LAD.
This percentage is greater than what has been previously
reported because the present study population was limited
in size and focused on symptomatic patients, resulting in
a greater pretest probability. To address the conflict of the
prognostic value of a zero calcium score, future studies inves-
tigating patient populations of varying pretest probability
for CAD and clinically relevant end points (rather than an
angiographic end point) are needed. Thus, despite CACS’
predictive power, the occurrence of cardiac events in patients
with negative calcium scores suggests that CACS should not
be used as a single-decision diagnostic parameter for CAD.
There are several limitations in our study. First, CACS
cannot be used to assess noncalcified soft plaques or calcified
plaques that are less than 130HU in density. Noncalcified
plaques with density less than 30HUand positive remodeling
are significant predictors of acute coronary syndrome [31].
Second, the patient number of 100 is relatively small in our
cohort; however, this was compensated by statistical analysis.
Our patients with CAD and cardiac events had significantly
higher calcium score than those without CAD (𝑃 < 0.001)
and cardiac events (𝑃 = 0.031), respectively.
Third, our study included symptomatic patients who
underwent clinically relevant 64-MSCT and subsequent
CCA. We acknowledge the subsequent selection and verifi-
cation biases that could have led to the positive correlation
between CACS and angiography findings. Ideally, this bias
could have been avoided by randomly assigning patients that
had undergone 64-MSCT CACS for verification of CAD
through conventional angiography, regardless of clinical
signs or symptoms. However, it would be unethical to ask
asymptomatic patients to undergo unnecessary CCA due
to its invasive nature. Furthermore, since our study only
focuses on symptomatic patients, our data can only suggest
a similar relationship between CACS and CAD to exist in
asymptomatic patients. The study also does not assess if any
subjects belonged to the intermediate risk group. Future stud-
ies would benefit from investigating the correlation among
CACS, CAD, and clinical or Framingham’s risks factors in
each patient.
In conclusion, this study further confirms the signifi-
cant relationship between the CACS and the prevalence of
cardiac events and the presence of CAD on a vessel-based
in addition to a patient-basis analysis. The prevalence of
cardiac events was significantly increased with an increase of
CACS. Increased CACS (>100) was also associated with an
increased frequency of multivessel disease and patients with
CACS > 1000 had a 100% incidence of CAD. Although our
data supports calcium screening as an additional filter before
coronary angiography in symptomatic patients, a zero CACS
could not exclude the presence of significant CAD.
Conflict of Interests
All authors assert that there is no conflict of interests
(both personal and institutional) regarding specific financial
interests that are relevant to the work conducted or reported
in this paper.
Acknowledgment
The study was supported in part by a Research Grant from
the National Science Council, No. NSC 95-2314-B-182A-131-
MY2.
8 BioMed Research International
References
[1] W. B. Kannel and A. Schatzkin, “Sudden death: lessons from
subsets in population studies,” Journal of the American College
of Cardiology, vol. 5, no. 6, supplement 1, pp. 141B–149B, 1985.
[2] M. J. Budoff and K. M. Gul, “Expert review on coronary
calcium,” Vascular Health and Risk Management, vol. 4, no. 2,
pp. 315–324, 2008.
[3] C. C. Chen, C. C. Chen, I. C. Hsieh et al., “The effect of
calcium score on the diagnostic accuracy of coronary computed
tomography angiography,” International Journal of Cardiovas-
cular Imaging, vol. 27, supplement 1, pp. 37–42, 2011.
[4] M. J. Budoff, S. Achenbach, R. S. Blumenthal et al., “Assessment
of coronary artery disease by cardiac computed tomography:
a scientific statement from the American Heart Associa-
tion Committee on Cardiovascular Imaging and Intervention,
Council on Cardiovascular Radiology and Intervention, and
Committee on Cardiac Imaging, Council on Clinical Cardiol-
ogy,” Circulation, vol. 114, no. 16, pp. 1761–1791, 2006.
[5] A. S. Agatston, W. R. Janowitz, F. J. Hildner, N. R. Zusmer, M.
Viamonte, and R. Detrano, “Quantification of coronary artery
calcium using ultrafast computed tomography,” Journal of the
American College of Cardiology, vol. 15, no. 4, pp. 827–832, 1990.
[6] P. Greenland, L. LaBree, S. P. Azen, T. M. Doherty, and R. C.
Detrano, “Coronary artery calcium score combined with fram-
ingham score for risk prediction in asymptomatic individuals,”
The Journal of the American Medical Association, vol. 291, no. 2,
pp. 210–215, 2004.
[7] D. Georgiou, M. J. Budoff, E. Kaufer, J. M. Kennedy, B. Lu,
and B. H. Brundage, “Screening patients with chest pain in
the emergency department using electron beam tomography: a
follow-up study,” Journal of the American College of Cardiology,
vol. 38, no. 1, pp. 105–110, 2001.
[8] G. Pundziute, J. D. Schuijf, J. W. Jukema et al., “Prognostic value
of multislice computed tomography coronary angiography in
patients with known or suspected coronary artery disease,”
Journal of the American College of Cardiology, vol. 49, no. 1, pp.
62–70, 2007.
[9] R. Detrano, A. D. Guerci, J. J. Carr et al., “Coronary calcium as a
predictor of coronary events in four racial or ethnic groups,”The
New England Journal ofMedicine, vol. 358, no. 13, pp. 1336–1345,
2008.
[10] M. Hadamitzky, R. Distler, T. Meyer et al., “Prognostic value of
coronary computed tomographic angiography in comparison
with calcium scoring and clinical risk scores,” Circulation, vol.
4, no. 1, pp. 16–23, 2011.
[11] E. S. Ma, Z. G. Yang, Y. Li, Z. H. Dong, L. Zhang, and L. L.
Qian, “Correlation of calcium measurement with low dose 64-
slice CT and angiographic stenosis in patients with suspected
coronary artery disease,” International Journal of Cardiology,
vol. 140, no. 2, pp. 249–252, 2010.
[12] Z. H. Hou, B. Lu, Y. Gao et al., “Prognostic value of coronary
CT angiography and calcium score for major adverse cardiac
events in outpatients,” JACC: Cardiovasc Imaging, vol. 5, no. 10,
pp. 990–999, 2012.
[13] I. C. Tsai, B.W. Choi, C. Chan et al., “ASCI 2010 appropriateness
criteria for cardiac computed tomography: a report of the
Asian Society of Cardiovascular Imaging cardiac computed
tomography and cardiacmagnetic resonance imaging guideline
Working Group,” International Journal of Cardiovascular Imag-
ing, vol. 26, no. 1, pp. 1–15, 2010.
[14] K. O. Akosah, A. Schaper, C. Cogbill, and P. Schoenfeld,
“Preventing myocardial infarction in the young adult in the
first place: how do the national cholesterol education panel
III guidelines perform?” Journal of the American College of
Cardiology, vol. 41, no. 9, pp. 1475–1479, 2003.
[15] P. Raggi, “Coronary-calcium screening to improve risk stratifi-
cation in primary prevention,”The Journal of the Louisiana State
Medical Society, vol. 154, no. 6, pp. 314–318, 2002.
[16] S. Möhlenkamp, N. Lehmann, P. Greenland et al., “coronary
artery calcium score improves cardiovascular risk prediction in
persons without indication for statin therapy,” Atherosclerosis,
vol. 215, pp. 229–236, 2011.
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